114 related articles for article (PubMed ID: 12897410)
1. Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions.
Jung F; Mrowietz C; Seyfert UT; Grewe R; Franke RP
Clin Hemorheol Microcirc; 2003; 28(4):189-99. PubMed ID: 12897410
[TBL] [Abstract][Full Text] [Related]
2. Light and scanning-electron microscopic examination of coronary stents in a perfusion-model. Effects of an NO-donor/quantitative analysis.
Franke RP; Reuter P; Mrowietz C; Bach R; Jung F
Clin Hemorheol Microcirc; 2001; 24(2):101-9. PubMed ID: 11381185
[TBL] [Abstract][Full Text] [Related]
3. Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents.
Mrowietz C; Franke RP; Seyfert UT; Park JW; Jung F
Clin Hemorheol Microcirc; 2005; 32(2):89-103. PubMed ID: 15764818
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of platelet glycoprotein IIb/IIIa receptor by nitric oxide donor 3-morpholino-sydnonimine.
Keh D; Thieme A; Kürer I; Falke KJ; Gerlach H
Blood Coagul Fibrinolysis; 2003 Jun; 14(4):327-34. PubMed ID: 12945873
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
Gerzer R; Drummer C; Karrenbrock B; Heim JM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
[TBL] [Abstract][Full Text] [Related]
6. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
Bult H; Fret HR; Herman AG
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689
[TBL] [Abstract][Full Text] [Related]
7. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of SIN-1 on thromboxane and prostacyclin formation in platelets and endothelial cells.
Lagarde M; Bordet JC; Croset M
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S95-7. PubMed ID: 2484709
[TBL] [Abstract][Full Text] [Related]
9. SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty.
Groves PH; Lewis MJ; Cheadle HA; Penny WJ
Circulation; 1993 Feb; 87(2):590-7. PubMed ID: 8425303
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of the vasodilating effect and blood platelet- antiaggregating activity of molsidomine and SIN-1].
Kukovetz WR; Holzmann S
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):260-5. PubMed ID: 3031569
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
Karrenbrock B; Grewe R; Loeschke K; Gerzer R
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
[TBL] [Abstract][Full Text] [Related]
12. Response of neonatal platelets to nitric oxide in vitro.
Keh D; Kürer I; Dudenhausen JW; Woltmann W; Falke KJ; Gerlach H
Intensive Care Med; 2001 Jan; 27(1):283-6. PubMed ID: 11280649
[TBL] [Abstract][Full Text] [Related]
13. The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.
Basista M; Grodzińska L; Swies J
Thromb Haemost; 1985 Dec; 54(4):746-9. PubMed ID: 3911480
[TBL] [Abstract][Full Text] [Related]
14. The antiadhesive and antithrombotic effects of the nitric oxide donor SIN-1 are combined with a decreased vasoconstriction in a porcine model of balloon angioplasty.
Provost P; Tremblay J; Merhi Y
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1806-12. PubMed ID: 9327781
[TBL] [Abstract][Full Text] [Related]
15. [Effects of nitric oxide on platelet function in burned rats].
Peng X; Feng J; Wang S
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1999 Nov; 15(6):428-30. PubMed ID: 11501077
[TBL] [Abstract][Full Text] [Related]
16. [Interaction between thrombocytes and the coronary system in the presence of SIN 1 and nitroglycerin after endothelial damage].
Rösen R; Bernards W; Jumpertz K; Kreie KJ; Wiesmüller G; Klaus W
Z Kardiol; 1991; 80 Suppl 5():23-7. PubMed ID: 1776331
[TBL] [Abstract][Full Text] [Related]
17. The effects of molsidomine and its metabolite SIN-1 on coronary vessel tone, platelet aggregation, and eicosanoid formation in vitro--inhibition of 12-HPETE biosynthesis.
Darius H; Ahland B; Rücker W; Klaus W; Peskar BA; Schrör K
J Cardiovasc Pharmacol; 1984; 6(1):115-21. PubMed ID: 6199592
[TBL] [Abstract][Full Text] [Related]
18. Modulation of platelet function by SIN-1A, a metabolite of molsidomine.
Wautier JL; Weill D; Kadeva H; Maclouf J; Soria C
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S111-4. PubMed ID: 2484687
[TBL] [Abstract][Full Text] [Related]
19. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation.
Shen EC; Chou TC; Gau CH; Tu HP; Chen YT; Fu E
Clin Oral Implants Res; 2006 Oct; 17(5):572-8. PubMed ID: 16958699
[TBL] [Abstract][Full Text] [Related]
20. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans.
Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M
Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
